ALDH1a1 has been implicated as an immunotherapy target in liver cancer through similar mechanisms as ALDH1a3 in sarcomas (Yu et al., 2024), suggesting that the immunotherapeutic-like effects of disulfiram in lung cancer may be due to ALDH1a1. The gene discussed is ALDH1A1; the disease is lung cancer.